AP1G1

protein-coding

adaptor related protein complex 1 subunit gamma 1, the group of Clathrin/coatomer adaptor, adaptin-like, N-terminal domain containing|Adaptor related protein complex 1|Small nucleolar RNA protein coding host genes

Gene summary

Adaptins are important components of clathrin-coated vesicles transporting ligand-receptor complexes from the plasma membrane or from the trans-Golgi network to lysosomes. The adaptin family of proteins is composed of four classes of molecules named alpha, beta-, beta prime- and gamma- adaptins. Adaptins, together with medium and small subunits, form a heterotetrameric complex called an adaptor, whose role is to promote the formation of clathrin-coated pits and vesicles. The protein encoded by this gene is a gamma-adaptin protein and it belongs to the adaptor complexes large subunits family. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Previous symbols:
  • CLAPG1
  • ADTG

MANE transcript

NM_001128.6

Inheritance

SD, AR, AD

ClinVar variants

P:26U:156B:45

Top phenotype

Usmani-Riazuddin syndrome, autosomal dominant

gnomAD constraint

pLI —, LoF o/e 0.1

Max pathogenic AF

—

Genomic locus

chr16:71,729,000-71,809,201

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~80.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

neurodevelopmental disorderSTRONG

Inheritance Pattern: SD

Disease ID:MONDO:0700092

Submitter: PanelApp Australia

Usmani-Riazuddin syndrome, autosomal recessiveLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0859196

Submitter: G2P

Usmani-Riazuddin syndrome, autosomal recessiveSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0859196

Submitter: Labcorp Genetics (formerly Invitae)

complex neurodevelopmental disorderSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0100038

Submitter: ClinGen

*AP1G1* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2021 (Usmani et al., PMID: 34102099). Of note, *AP1G1* has also been implicated in autosomal recessive complex neurodevelopmental disorder (Usmani-Riazuddin syndrome, autosomal recessive). The split curation for Usmani-Riazuddin syndrome, autosomal recessive, is assessed separately. *AP1G1*-related autosomal dominant complex neurodevelopmental disorder (also known as Usmani-Riazuddin syndrome, autosomal dominant) is characterized by global developmental delay with variably impaired intellectual development, speech delay, and behavioral abnormalities, including aggression, hyperactivity, and autism spectrum disorder or autistic features. Additional common features include seizures, hypotonia, and distal limb anomalies. Five de novo missense variants and three de novo loss-of-function variants have been reported in nine unrelated patients (PMID: 34102099). This gene-disease relationship is also supported by experimental evidence. AP1G1 interacts with other adaptor protein complex 1 (AP-1) proteins, AP1S1/AP1S2, which have been definitively implicated in neurodevelopmental disorders. AP complexes mediate selective intracellular vesicular trafficking and polarized localization of somatodendritic proteins in neurons. In summary, there is strong evidence to support this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 2, 2022 (SOP Version 9).

complex neurodevelopmental disorderLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0100038

Submitter: ClinGen

*AP1G1* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2021 (Usmani et al., PMID: 34102099). Of note, *AP1G1* has also been implicated in autosomal dominant complex neurodevelopmental disorder (Usmani-Riazuddin syndrome, autosomal dominant). The split curation for Usmani-Riazuddin syndrome, autosomal dominant, is assessed separately. *AP1G1*-related autosomal recessive complex neurodevelopmental disorder (also known as Usmani-Riazuddin syndrome, autosomal recessive) has been reported in three affected individuals from two unrelated consanguineous families carrying homozygous missense variants functionally characterized in cell culture and zebrafish models (PMID: 34102099). Common features in affected individuals included global developmental delay, hypotonia, speech delay, moderately to severely impaired intellectual development, and spasticity. This gene-disease relationship is also supported by experimental evidence. AP1G1 interacts with other adaptor protein complex 1 (AP-1) proteins, AP1S1/AP1S2, which have been definitively implicated in neurodevelopmental disorders. AP complexes mediate selective intracellular vesicular trafficking and polarized localization of somatodendritic proteins in neurons. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 2, 2022 (SOP Version 9).

Usmani-Riazuddin syndrome, autosomal dominantSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0859174

Submitter: Labcorp Genetics (formerly Invitae)

Usmani-Riazuddin syndrome, autosomal dominantSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0859174

Submitter: G2P

Clinical Genomic Database (CGD)

Usmani-Riazuddin syndrome, autosomal dominantAD/AR

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 34102099Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to AP1G1 variants in ClinVar

8 Conditions Cataloged
Inborn genetic diseasesTotal: 83
not providedTotal: 81
Usmani-Riazuddin syndrome, autosomal dominantTotal: 31
not specifiedTotal: 22
AP1G1-related disorderTotal: 18
Usmani-Riazuddin syndrome, autosomal recessiveTotal: 6
Neurodevelopmental disorderTotal: 1
See casesTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001128.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
4
clinvar
14
clinvar
19
missense
3
clinvar
3
clinvar
129
clinvar
31
clinvar
166
nonsense
5
clinvar
3
clinvar
8
clinvar
16
start loss
0
frameshift
5
clinvar
2
clinvar
7
clinvar
14
splice donor/acceptor (+/-2bp)
2
clinvar
2
clinvar
8
clinvar
12
Total1511156450227

Highest pathogenic variant AF is 0.000008055591

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 55 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001128.6RefSeqNP_001119.322MANE Select
ENST00000299980.9EnsemblENSP00000299980.422MANE Select
NM_001030007.2RefSeqNP_001025178.123Standard
ENST00000393512.7EnsemblENSP00000377148.323Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
ap1g1Danio rerio

Structure: blood cell

Quality: mislocalised

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Lysosome - Homo sapiens (human)
  • Golgi Associated Vesicle Biogenesis
  • Lysosome Vesicle Biogenesis
  • Clathrin derived vesicle budding
  • Disease

Biological Process

  • intracellular protein transport
  • antigen processing and presentation of exogenous peptide antigen via MHC class II
  • melanosome organization
  • endosome to melanosome transport
  • positive regulation of natural killer cell degranulation

Molecular Function

  • transporter activity
  • protein binding
  • Rab GTPase binding
  • kinesin binding
  • GTP-dependent protein binding

Cellular Component

  • Golgi membrane
  • cytoplasm
  • lysosomal membrane
  • Golgi apparatus
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000393512
Coding exons
23
Length
80192
Individuals with no LoFs
125742
Homozygous LoFs
0
Heterozygous LoFs
5
Defined
125747
p
0.0000199
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.982774560.6070.00002425382
Missense (PolyPhen)47158.580.296371872
Synonymous-0.3031651601.030.000007961605
Loss of Function6.05552.20.09590.00000333569

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000630.000058rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000470.000046rare
European (Non-Finnish)0.0000180.000018rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules.;

Recessive Scores

pRec
0.119

Intolerance Scores

LoFtool
0.247
RVIS EVS
-0.76
RVIS percentile EVS
13.45

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.961

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.